Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Next shareholder meeting - January 28, 2010 - HHHHHHAAAAAAAA

<From my opinion being in the NorthEast, I can now consider going.>

That's an interesting statement. I'm from NY, and I consider the risk too great. While getting into and out of Chicago is a potential problem for some, I would have to worry about getting out of and back into New York as well. It's a double whammy. Too much risk for this New Yorker.

GLTA, Opty

Share
New Message
Please login to post a reply